First American Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
AAMU
AIM
AV
MIF
ZIC
First American Bank's AZN Position: Q2 2026 in Review
First American Bank reduced its AstraZeneca (AZN) stake by 0.45% in Q2 2026, selling an estimated $9.4K and leaving 10,959 shares worth $2.08M. The position accounts for 0.12% of the portfolio, ranked #109.
First American Bank first reported a position in AZN in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.57M in Q2 2022. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- First American Bank held 10,959 shares of AstraZeneca worth $2.08M as of Q2 2026.
- First American Bank sold 50 AstraZeneca shares in Q2 2026, an estimated $9.4K.
- AstraZeneca made up 0.12% of First American Bank's portfolio in Q2 2026, its #109 holding.
- First American Bank first reported a position in AstraZeneca in Q1 2022 and has held it in 18 quarters since.
- First American Bank's AstraZeneca position peaked at $5.57M in Q2 2022.
- 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.